Also trades as: CDIO (NASDAQ) · $vol 5M
CDIOW NASDAQ
Cardio Diagnostics Holdings, Inc.
1W: -0.7%
1M: -43.2%
3M: -24.7%
YTD: -35.3%
1Y: -55.3%
3Y: -92.8%
$0.01
-0.00 (-2.80%)
Weekly Expected Move ±95.3%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0116-0.0189
Volume4,962
Avg Volume41,344
Beta2.26
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMeeshanthini V. Dogan
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-14
Websitecardiodiagnosticsinc.com
400 N Aberdeen St
Chicago, IL 60642
US
Chicago, IL 60642
US
855 226 9991
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fung Peter K | A-Award | 18,939 | $0.33 | 2025-03-31 |
| Betts Wendy J | A-Award | 18,939 | $0.33 | 2025-03-31 |
| Burton Paul Frederic | A-Award | 18,939 | $0.33 | 2025-03-31 |
| Intrater James | A-Award | 18,939 | $0.33 | 2025-03-31 |
| Fung Peter K | 2,272 | $0.92 | 2024-12-31 |